Skip to main content
Eliot A. Brinton

Eliot A. Brinton, MD

Languages spoken: English, Spanish

Board Certification

  • American Board of Internal Medicine (Internal Medicine)

Research Interests

  • Lipids
  • Lipoproteins
  • Lipoproteins, HDL
  • Lipoprotein(a)
  • Lipoproteins, LDL
  • Diabetes Mellitus
  • Estrogen Replacement Therapy
  • Menopause
  • Arteriosclerosis
  • Atherosclerosis
  • Metabolic Syndrome X
  • Cardiovascular Diseases
  • Coronary Arteriosclerosis
  • Preventive Cardiology
  • Carotid Artery Diseases
  • Peripheral Vascular Diseases
  • Hyperlipoproteinemia
  • Hyperlipidemia
  • Triglycerides
  • Lipase
  • Xanthomatosis
  • Tangier Disease

Education History

Fellowship University of Washington School of Medicine
Fellow
Residency Duke University Medical Center
Resident
Internship Duke University Medical Center
Intern
Professional Medical University of Utah
MD
Undergraduate University of Utah
BS

Selected Publications

Journal Article

  1. Manson JE, Bassuk SS, Harman SM, Brinton EA, Cedars MI, Lobo R, Merriam GR, Miller VM, Naftolin F, Santoro N (2006). Postmenopausal hormone therapy: new questions and the case for new clinical trials. Menopause, 13(1), 139-47. (Read full article)
  2. Brinton EA (2005). Controversies in dyslipidemias: atheroprevention in diabetes and insulin resistance. Ann N Y Acad Sci, 1055, 159-78. (Read full article)
  3. Hopkins PN, Wu LL, Hunt SC, Brinton EA (2005). Plasma triglycerides and type III hyperlipidemia are independently associated with premature familial coronary artery disease. J Am Coll Cardiol, 45(7), 1003-12. (Read full article)
  4. Kuivenhoven JA, Hovingh GK, van Tol A, Jauhiainen M, Ehnholm C, Fruchart JC, Brinton EA, Otvos JD, Smelt AH, Brownlee A, Zwinderman AH, Hayden MR, Kastelein JJ (2003). Heterozygosity for ABCA1 gene mutations: effects on enzymes, apolipoproteins and lipoprotein particle size. Atherosclerosis, 171(2), 311-9. (Read full article)

Editorial

  1. Brinton EA, Nanjee MN, Hopkins PN (2004). Triglyceride-rich lipoprotein remnant levels and metabolism: time to adopt these orphan risk factors? J Am Coll Cardiol, 43(12), 2233-5. (Read full article)